Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits

Overview

Journal Front Neurosci

Date 2018 Jun 29

PMID 29950970

Citations 107

Authors

Shreyasi Chatterjee

Amritpal Mudher

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) and Type 2 Diabetes Mellitus (T2DM) are two of the most prevalent diseases in the elderly population worldwide. A growing body of epidemiological studies suggest that people with T2DM are at a higher risk of developing AD. Likewise, AD brains are less capable of glucose uptake from the surroundings resembling a condition of brain insulin resistance. Pathologically AD is characterized by extracellular plaques of Aβ and intracellular neurofibrillary tangles of hyperphosphorylated tau. T2DM, on the other hand is a metabolic disorder characterized by hyperglycemia and insulin resistance. In this review we have discussed how Insulin resistance in T2DM directly exacerbates Aβ and tau pathologies and elucidated the pathophysiological traits of synaptic dysfunction, inflammation, and autophagic impairments that are common to both diseases and indirectly impact Aβ and tau functions in the neurons. Elucidation of the underlying pathways that connect these two diseases will be immensely valuable for designing novel drug targets for Alzheimer's disease.

Citing Articles

Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease.

Arnold M, Buyukozkan M, Doraiswamy P, Nho K, Wu T, Gudnason V Nat Commun. 2025; 16(1):1910.

PMID: 39994231 PMC: 11850607. DOI: 10.1038/s41467-025-57032-0.

Amyloid-β and heart failure in Alzheimer's disease: the new vistas.

Al-Kuraishy H, Sulaiman G, Mohammed H, Mohammed S, Al-Gareeb A, Albuhadily A Front Med (Lausanne). 2025; 12:1494101.

PMID: 39967593 PMC: 11832649. DOI: 10.3389/fmed.2025.1494101.

Trends in Alzheimer's-Related Mortality Among Type 2 Diabetes Patients in the United States: 1999-2019.

Waqas S, Ali D, Khan T, Qureshi S, Siddiqui H, Sajid M Endocrinol Diabetes Metab. 2025; 8(2):e70032.

PMID: 39899444 PMC: 11789764. DOI: 10.1002/edm2.70032.

Associations Between Diabetes Mellitus and Neurodegenerative Diseases.

Szablewski L Int J Mol Sci. 2025; 26(2).

PMID: 39859258 PMC: 11765393. DOI: 10.3390/ijms26020542.

Advancing Alzheimer's Disease Modelling by Developing a Refined Biomimetic Brain Microenvironment for Facilitating High-Throughput Screening of Pharmacological Treatment Strategies.

Mohd Murshid N, Mohd Sahardi N, Makpol S Int J Mol Sci. 2025; 26(1.

PMID: 39796097 PMC: 11719782. DOI: 10.3390/ijms26010241.

References

Back S, Kaufman R . Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem. 2012; 81:767-93. PMC: 3684428. DOI: 10.1146/annurev-biochem-072909-095555. View

Ferreira S, Lourenco M, Oliveira M, De Felice F . Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front Cell Neurosci. 2015; 9:191. PMC: 4443025. DOI: 10.3389/fncel.2015.00191. View

Wennberg A, Spira A, Pettigrew C, Soldan A, Zipunnikov V, Rebok G . Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults. J Neurol Sci. 2016; 365:89-95. PMC: 4876973. DOI: 10.1016/j.jns.2016.04.017. View

Zhang W, Thompson B, Hietakangas V, Cohen S . MAPK/ERK signaling regulates insulin sensitivity to control glucose metabolism in Drosophila. PLoS Genet. 2012; 7(12):e1002429. PMC: 3248469. DOI: 10.1371/journal.pgen.1002429. View

Sakono M, Zako T . Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J. 2010; 277(6):1348-58. DOI: 10.1111/j.1742-4658.2010.07568.x. View

Zotova E, Nicoll J, Kalaria R, Holmes C, Boche D . Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 2010; 2(1):1. PMC: 2874260. DOI: 10.1186/alzrt24. View

Bradley C, Peineau S, Taghibiglou C, Nicolas C, Whitcomb D, Bortolotto Z . A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci. 2012; 5:13. PMC: 3279748. DOI: 10.3389/fnmol.2012.00013. View

Jo C, Gundemir S, Pritchard S, Jin Y, Rahman I, Johnson G . Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun. 2014; 5:3496. PMC: 3990284. DOI: 10.1038/ncomms4496. View

Cheng C, Tseng V, Wang J, Wang D, Matyakhina L, Bondy C . Tau is hyperphosphorylated in the insulin-like growth factor-I null brain. Endocrinology. 2005; 146(12):5086-91. DOI: 10.1210/en.2005-0063. View

10.

Hu N, Tan M, Sun L, Jiang T, Wang Y, Tan L . Decreased expression of CD33 in peripheral mononuclear cells of Alzheimer's disease patients. Neurosci Lett. 2014; 563:51-4. DOI: 10.1016/j.neulet.2014.01.004. View

11.

Dolan P, Johnson G . A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol Chem. 2010; 285(29):21978-87. PMC: 2903354. DOI: 10.1074/jbc.M110.110940. View

12.

Mosconi L, Pupi A, de Leon M . Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci. 2008; 1147:180-95. PMC: 2661241. DOI: 10.1196/annals.1427.007. View

13.

Yiannopoulou K, Papageorgiou S . Current and future treatments for Alzheimer's disease. Ther Adv Neurol Disord. 2013; 6(1):19-33. PMC: 3526946. DOI: 10.1177/1756285612461679. View

14.

Minkeviciene R, Rheims S, Dobszay M, Zilberter M, Hartikainen J, Fulop L . Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci. 2009; 29(11):3453-62. PMC: 6665248. DOI: 10.1523/JNEUROSCI.5215-08.2009. View

15.

Bierer L, Hof P, Purohit D, Carlin L, Schmeidler J, Davis K . Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol. 1995; 52(1):81-8. DOI: 10.1001/archneur.1995.00540250089017. View

16.

Smet-Nocca C, Broncel M, Wieruszeski J, Tokarski C, Hanoulle X, Leroy A . Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation. Mol Biosyst. 2011; 7(5):1420-9. DOI: 10.1039/c0mb00337a. View

17.

Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D . Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging. 2009; 32(5):763-77. DOI: 10.1016/j.neurobiolaging.2009.04.016. View

18.

Nixon R . Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007; 120(Pt 23):4081-91. DOI: 10.1242/jcs.019265. View

19.

Moreira P, Santos M, Moreno A, Seica R, Oliveira C . Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure. Diabetes. 2003; 52(6):1449-56. DOI: 10.2337/diabetes.52.6.1449. View

20.

van der Heide L, Kamal A, Artola A, Gispen W, Ramakers G . Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem. 2005; 94(4):1158-66. DOI: 10.1111/j.1471-4159.2005.03269.x. View